Phillip Frost - Jul 18, 2023 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Signature
/s/ Phillip Frost, MD, ET AL__
Stock symbol
COCP
Transactions as of
Jul 18, 2023
Transactions value $
$0
Form type
4
Date filed
7/20/2023, 04:05 PM
Previous filing
May 19, 2023
Next filing
Aug 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCP Stock Options (Right to Buy) Award $0 +19.3K $0.00 19.3K Jul 18, 2023 Common Stock 19.3K $2.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.